Loading…
Stereotaxis, Inc. is projected to rise to $2.62 by 2027, a +31% move from its current price of $2.01. STXS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.96 | $2.01 | $2.06 | +0.01% |
| May 30 | $1.94 | $2.01 | $2.08 | +0.02% |
| May 31 | $1.93 | $2.01 | $2.10 | +0.04% |
| Jun 1 | $1.91 | $2.01 | $2.11 | +0.05% |
| Jun 2 | $1.90 | $2.01 | $2.13 | +0.06% |
| Jun 3 | $1.89 | $2.01 | $2.14 | +0.07% |
| Jun 4 | $1.88 | $2.01 | $2.15 | +0.08% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.88 | $2.01 | $2.15 | +0.08% |
| Week 2 | $1.83 | $2.01 | $2.21 | +0.17% |
| Week 3 | $1.80 | $2.02 | $2.26 | +0.25% |
| Week 4 | $1.77 | $2.02 | $2.30 | +0.34% |
| Week 5 | $1.74 | $2.02 | $2.34 | +0.42% |
| Week 6 | $1.72 | $2.02 | $2.38 | +0.51% |
| Week 7 | $1.70 | $2.02 | $2.41 | +0.59% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.
It offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems. It markets Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems.
In addition, the company offers disposables and other accessories, including MAGiC catheter, a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures; MAGiC Sweep, a mapping catheter; QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; and V-CAS devices. Further, it provides interventional devices under the Map-iT, MAGiC, and EMAGIN brands, and other related devices. Stereotaxis, Inc.
was incorporated in 1990 and is based in Saint Louis, Missouri.
STXS is a healthcare stock trading with a current price of $1.92 and a market capitalization of $187.65M, holding a rank of 3880.
The multi-year price outlook shows a path of gradual appreciation, with the 2026 forecast averaging $1.92 and long-run projections rising to $9.67 by 2050, while max forecasts reach $17.47. The 2030, 2040, and 2050 forecasted averages are $2.85, $5.67, and $9.67 respectively, with corresponding max values of $4.11, $9.41, and $17.47 and ROIs of 48.6, 195.4, and 403.7, reflecting a bullish long-term trajectory.
Across the forecast horizon, sentiment is predominantly bullish after 2026, supporting a gradual uplift in intrinsic expectations over time.
A major floor 19.2% below — a decisive break under it would weaken the trend.
The nearest floor, 13.9% below — buyers have tended to step in here.
Price is pressing into resistance (1.0% away) — a breakout level to watch.
A major ceiling 36.8% above — clearing it would confirm fresh momentum.
Key STXS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of STXS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.93 | Buy | $1.94 | Buy |
| MA 10 | $1.88 | Buy | $1.91 | Buy |
| MA 20 | $1.89 | Buy | $1.90 | Buy |
| MA 50 | $1.89 | Buy | $1.94 | Buy |
| MA 100 | $2.08 | Sell | $2.06 | Sell |
| MA 200 | $2.40 | Sell | $2.19 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 58.64 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 175.97 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 5.79 | Buy |
| Bollinger %B (20,2) | 1.01 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.10 | Sell |
| Awesome (5,34) | 0.01 | Buy |
| Ultimate (7,14,28) | 63.19 | Neutral |
| Momentum (10) | 0.09 | Buy |
| Aroon Osc (25) | 20.00 | Buy |
| Hull MA (9) | 1.98 | Buy |
| ADX (14) | 9.90 | Neutral |
| ATR (14) | 0.05 | Info |
30-day technical picture: sentiment is BULLISH, RSI14 is 50, SMA50 is $1.89, and SMA200 is $2.41. Support is at $1.73 and resistance at $2.03.
The 30-day range spans from $1.62 to $2.27, illustrating a relatively tight trading band around the current level with potential for a move toward the near-term resistance. Annualized volatility sits around 50%, indicating a moderately high level of price fluctuation over the year.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.73 | $2.01 | $2.88 | 0% | Neutral | |
| $2.10 | $2.62 | $3.47 | +31% | Bullish | |
| $2.15 | $2.75 | $3.76 | +37% | Bullish | |
| $2.11 | $2.76 | $3.87 | +37% | Bullish | |
| $2.26 | $3.01 | $4.31 | +50% | Bullish | |
| $2.22 | $3.01 | $4.40 | +50% | Bullish | |
| $2.33 | $3.20 | $4.76 | +59% | Bullish | |
| $2.92 | $4.08 | $6.17 | +103% | Bullish | |
| $3.02 | $4.27 | $6.55 | +113% | Bullish | |
| $3.00 | $4.31 | $6.70 | +114% | Bullish | |
| $3.95 | $6.02 | $9.92 | +200% | Bullish | |
| $6.06 | $10.22 | $18.31 | +408% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.73 | $2.01 | $2.37 | +0.00% |
| June 2026 | $1.76 | $2.06 | $2.47 | +2.46% |
| July 2026 | $1.72 | $2.03 | $2.47 | -1.32% |
| August 2026 | $1.71 | $2.04 | $2.50 | +0.21% |
| September 2026 | $1.79 | $2.14 | $2.64 | +5.08% |
| October 2026 | $1.85 | $2.22 | $2.76 | +3.54% |
| November 2026 | $1.84 | $2.22 | $2.78 | +0.31% |
| December 2026 | $1.89 | $2.29 | $2.88 | +3.02% |
Click any year to see its month-by-month STXS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, STXS is projected to trade between $1.73 and $2.88, averaging $2.01 — a potential gain of 0% from today's $2.01. A consolidation phase looks the most probable path here.
Stereotaxis, Inc.'s 2027 outlook centres on $2.62, within a $2.10 to $3.47 range. That is up +31% on the projected 2026 average. That marks a +31% change versus current levels. Momentum favours further upside here.
By 2028, STXS could reach as high as $3.76, with a base case around $2.75 and support toward $2.15 — roughly +37% from $2.01. Buyers look set to stay in control over this stretch.
Expect STXS to range from $2.11 to $3.87 through 2029. The $2.76 average target implies a +37% move from current prices. That is up 0% on the projected 2028 average. Momentum favours further upside here.
The STXS price prediction for 2030 points to an average of $3.01 (low $2.26, high $4.31) — a potential gain of +50% on today's $2.01. Buyers look set to stay in control over this stretch.
In 2031, STXS is projected to trade between $2.22 and $4.40, averaging $3.01 — a potential gain of +50% from today's $2.01. That is up 0% on the projected 2030 average. Momentum favours further upside here.
Stereotaxis, Inc.'s 2032 outlook centres on $3.20, within a $2.33 to $4.76 range. That is up +6% on the projected 2031 average. That marks a +59% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, STXS could reach as high as $6.17, with a base case around $4.08 and support toward $2.92 — roughly +103% from $2.01. Momentum favours further upside here.
Expect STXS to range from $3.02 to $6.55 through 2034. The $4.27 average target implies a +113% move from current prices. That is up +5% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The STXS price prediction for 2035 points to an average of $4.31 (low $3.00, high $6.70) — a potential gain of +114% on today's $2.01. Momentum favours further upside here.
In 2040, STXS is projected to trade between $3.95 and $9.92, averaging $6.02 — a potential gain of +200% from today's $2.01. That is up +40% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Stereotaxis, Inc.'s 2050 outlook centres on $10.22, within a $6.06 to $18.31 range. That is up +70% on the projected 2040 average. That marks a +408% change versus current levels. Momentum favours further upside here.
Investing $1,000 in STXS today (≈ 497.512438 STXS) could be worth
$5,082.97
+$4,082.97 (+408%) by 2050 · US Dollar
Based on the average projected STXS price of $10.22 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in STXSwould be worth at today's price.
$1,000 invested in STXS on May 27, 2025 (≈ 469.483543 STXS) would be worth
$943.66
-$56.34 (-5.6%) today · 0.94× · US Dollar
Based on a STXS entry price of $2.13 vs. today's $2.01.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.85 | $1,086.49 | +8.6% |
| 1 month ago | $1.93 | $1,041.45 | +4.1% |
| 3 months ago | $2.21 | $909.5 | -9.0% |
| 6 months ago | $2.46 | $817.07 | -18.3% |
| 1 year ago | $2.13 | $943.66 | -5.6% |
| All time (5.0y) ago | $7.83 | $256.7 | -74.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our STXS forecast.
Our base-case forecast reaches $4.00 around 2033.
Implied market cap at $4.00: $390.95M
The multi-year forecast paints a bullish trajectory beyond 2026, with notable milestones in key years. In 2030, the average price is projected at $2.85, with a min of $2.13 and a max of $4.11, and a 48.6 ROI alongside a bullish sentiment. By 2040 the average rises to $5.67, the max to $9.41, and the ROI to 195.4, with continued bullish sentiment.
By 2050 the average is forecast at $9.67, the max at $17.47, and the ROI at 403.7, remaining bullish. The years 2027 through 2050 show extending bullish sentiment with increasing price levels and higher ROIs, culminating in a substantially larger potential over the long term. These figures are estimates and not guarantees; actual results depend on market conditions and other factors.
Tap a question to reveal the answer.
2030 min $2.13, avg $2.85, max $4.11, ROI 48.6, sentiment BULLISH.
The forecast shows BULLISH sentiment from 2027 onward with rising averages and a high long-term ROI, including ROI 403.7 by 2050.
Yes—the 2050 max is $17.47, which would exceed $10.
Current price is $1.92; Market cap is $187.65M.
2040 min $3.70, avg $5.67, max $9.41, ROI 195.4, sentiment BULLISH.
Stereotaxis, Inc. Community Discussion
0Share your Stereotaxis, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.